Patents-Review.com
ClassID:

108830 ⎘

C12N5/163 - CPC Classification

Classification description:

Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Cells modified by introduction of foreign genetic material; Fused cells, e.g. hybridomas; Animal cells one of the fusion partners being a B or a T lymphocyte

Recent Application in this class:
#1
20260109783
2026-04-23

ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE

 #2
20250388651
2025-12-25

TRANSGENIC CHICKEN THAT MAKES ANTIBODIES WITH LONG CDR-H3S STABILIZED BY MULTIPLE DISULFIDE BRIDGES AND DIVERSIFIED BY GENE CONVERSION

 #3
20250382381
2025-12-18

TARGETING ART1 FOR CANCER IMMUNOTHERAPY

 #4
20250188157
2025-06-12

ANTIBODY BINDING TO CLOSTRIDIUM DIFFICILE

 #5
20250154269
2025-05-15

IL3Ra Antibody Conjugates and Uses Thereof

 #6
20250092149
2025-03-20

BAFF-R TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T-CELLS AND USES THEREOF

 #7
20250060372
2025-02-20

Methods of Culturing and Characterizing Antibody Secreting Cells

 #8
20250026817
2025-01-23

Anti-Bed Bug Monoclonal Antibodies and Methods of Making and Uses Thereof

 #9
20240358830
2024-10-31

ANTIGEN PRESENTING CELL/TARGET CELL HYBRIDOMA-DERIVED VACCINES

 #10
20240191207
2024-06-13

METHODS AND COMPOSITIONS FOR INDUCIBLE EXTRACELLULAR MEMBRANE CAPTURE OF MONOCLONAL IMMUNOGLOBULINS SECRETED BY HYBRIDOMAS

 #11
20240094218
2024-03-21

ENHANCED HYBRIDOMA GENERATION

 #12
20240052311
2024-02-15

END-TO-END CELL THERAPY AUTOMATION

 #13
20230365665
2023-11-16

ANTIBODY COMPOSITIONS TARGETING NON-PHOSPHORYLATED a-SYNUCLEIN AGGREGATES

 #14
20230183654
2023-06-15

METHOD FOR SELECTING HYBRIDOMA CELLS FROM A PLURALITY OF HYBRIDOMA CELLS BY MEANS OF A BIRA EXPRESSION VECTOR

 #15
20230165947
2023-06-01

CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE

 #16
20230159878
2023-05-25

DETERMINISTIC HYBRIDOMA GENERATION VIA MICROFLUIDICS

 #17
20230040878
2023-02-09

METHOD FOR PREPARING GENETICALLY-MODIFIED T CELLS WHICH EXPRESS CHIMERIC ANTIGEN RECEPTOR

 #18
20230016357
2023-01-19

DETERMINISTIC HYBRIDOMA GENERATION VIA MICROFLUIDICS

 #19
20220282214
2022-09-08

End-to-end cell therapy automation

 #20
20220282213
2022-09-08

End-to-end cell therapy automation

 #21
20220282212
2022-09-08

END-TO-END CELL THERAPY AUTOMATION

 #22
20220218805
2022-07-14

CONFORMATION-SPECIFIC EPITOPES IN TAU, ANTIBODIES THERETO AND METHODS RELATED THEREOF

 #23
20220178929
2022-06-09

BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETO

 #24
20220099687
2022-03-31

POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP

 #25
20220096547
2022-03-31

MODIFIED IMMUNE CELLS EXPRESSING FLAGELLIN POLYPEPTIDE

 #26
20220089708
2022-03-24

ANTIBODY COMPOSITIONS TARGETING NON-PHOSPHORYLATED ALPHA-SYNUCLEIN AGGREGATES

 #27
20220023421
2022-01-27

METHODS FOR ELICITING SELECTIVE HUMORAL RESPONSES

 #28
20220010023
2022-01-13

BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

 #29
20210382066
2021-12-09

Methods of culturing and characterizing antibody secreting cells

 #30
20210355226
2021-11-18

IL3Ralpha antibodies and uses thereof

 #31
20210324342
2021-10-21

Method of making exosomes from tumor cell/antigen presenting cell hybrid cells

 #32
20210230253
2021-07-29

TRANSGENIC CHICKEN THAT MAKES ANTIBODIES WITH LONG CDR-H3S STABILIZED BY MULTIPLE DISULFIDE BRIDGES AND DIVERSIFIED BY GENE CONVERSION

 #33
20210087276
2021-03-25

Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using

 #34
20210000088
2021-01-07

TRANSGENIC CHICKEN THAT PRODUCES HUMAN ANTIBODIES

 #35
20210000087
2021-01-07

TRANSGENIC MAMMALS AND METHODS OF USE THEREOF

 #36
20200363405
2020-11-19

Anti-bed bug monoclonal antibodies and methods of making and uses thereof

 #37
20200339666
2020-10-29

DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof

 #38
20200332023
2020-10-22

Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase

 #39
20200330514
2020-10-22

T cells surface-loaded with immunostimulatory fusion molecules and uses thereof

 #40
20200306301
2020-10-01

Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof

 #41
20200190480
2020-06-18

ANTIBODIES AGAINST ASPARTYL (ASPARAGINYL) beta-HYDROXYLASE (AABH) AND METHODS OF MAKING AND USING

 #42
20200140828
2020-05-07

Cytotoxic antibody

 #43
20200079869
2020-03-12

Anti-CD47 monoclonal antibody and use thereof

 #44
20200071670
2020-03-05

End-to-end cell therapy automation

 #45
20200016252
2020-01-16

Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide

 #46
20200010810
2020-01-09

Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas

 #47
20200010536
2020-01-09

Human monoclonal antibodies to lukab toxin

 #48
20190352614
2019-11-21

B-CELL ENGINEERING

 #49
20190315874
2019-10-17

IL3Ralpha antibody conjugates and uses thereof

 #50
20190263917
2019-08-29

BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

 #51
20190247431
2019-08-15

Activated CD26-high immune cells and CD26-negative immune cells and uses thereof

 #52
20190204324
2019-07-04

Antigenic composition for detecting auto-antibody with specific response to exosomal protein EIF3A, and method for diagnosing liver cancer using antigenic composition

 #53
20190169572
2019-06-06

End-to-end cell therapy automation

 #54
20190112358
2019-04-18

DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof

 #55
20190100574
2019-04-04

Antibodies specific for enteroviruses that infect humans

 #56
20190054120
2019-02-21

Compositions and methods for isolating and enriching IgM-producing cells and uses thereof

 #57
20190048056
2019-02-14

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

 #58
20180371095
2018-12-27

Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using

 #59
20180371070
2018-12-27

Antibodies for detecting redox modulated proteins

 #60
20180369285
2018-12-27

Chimeric antigen receptor targeting human NKG2DL and methods of preparing said receptor and pharmaceutical composition

 #61
20180340942
2018-11-29

Methods of culturing and characterizing antibody secreting cells

 #62
20180326031
2018-11-15

Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide

 #63
20180312596
2018-11-01

IL3Rα antibody conjugates and uses thereof

 #64
20180291075
2018-10-11

Use of IL-15 to increase thymic output and to treat lymphopenia

 #65
20180289742
2018-10-11

Method for preparing genetically-modified T cells which express chimeric antigen receptor

 #66
20180186895
2018-07-05

Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof

 #67
20180134799
2018-05-17

Antibodies, pharmaceutical compositions and uses thereof

 #68
20180009905
2018-01-11

ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE

 #69
20170343569
2017-11-30

Antibodies to olanzapine haptens and use thereof

 #70
20170326175
2017-11-16

Method for induction of T cells from pluripotent stem cells

 #71
20170298116
2017-10-19

Method for producing antigen-specific B cells and their use for the production of hybridoma cells and monoclonal antibodies

 #72
20170292118
2017-10-12

Method for modulating car-induced immune cells activity

 #73
20170267782
2017-09-21

Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)

 #74
20170240653
2017-08-24

Antibodies to olanzapine haptens and use thereof

 #75
20170159025
2017-06-08

Nucleic acids encoding chimeric antigen receptor proteins which bind epidermal growth factor receptor and T lymphocyte expressing the protein

 #76
20170137501
2017-05-18

Anti-bed bug monoclonal antibodies and methods of making and uses thereof

 #77
20170101460
2017-04-13

TRANSGENIC ANIMALS CAPABLE OF PRODUCING HUMANIZED IGE AT MUCH HIGHER LEVELS THAN MOUSE IGE

 #78
20170029526
2017-02-02

Antibodies, pharmaceutical compositions and uses thereof

 #79
20170010288
2017-01-12

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

 #80
20170002331
2017-01-05

Cytotoxic antibody

 #81
20160376670
2016-12-29

Eukaryotic cells with artificial endosymbionts for multimodal detection

 #82
20160333075
2016-11-17

Antibodies specific for enteroviruses that infect humans

 #83
20160324131
2016-11-10

Transgenic transchromosomal rodents for making human antibodies

 #84
20160304625
2016-10-20

Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereof

 #85
20160264683
2016-09-15

Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase

 #86
20160207982
2016-07-21

Fusion partner for production of monoclonal rabbit antibodies

 #87
20160199518
2016-07-14

Eukaryotic cells with artificial endosymbionts for multimodal detection

 #88
20160185873
2016-06-30

Monoclonal anti-GT 468 antibodies for treatment of cancer

 #89
20160159925
2016-06-09

Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof

 #90
20160076002
2016-03-17

Bioassay for cell conditioned media

 #91
20160031994
2016-02-04

IL3Rα antibody conjugates and uses thereof

 #92
20160017027
2016-01-21

Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4

 #93
20160009790
2016-01-14

Anti-Vasohibin 2 antibody

 #94
20150361165
2015-12-17

MFAP4 binding antibodies blocking the interaction between MFAP4 and integrin receptors

 #95
20150299308
2015-10-22

Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof

 #96
20150291687
2015-10-15

Compositions and methods for redox modulated proteins

 #97
20150275182
2015-10-01

Eukaryotic cells with artificial endosymbionts for multimodal detection

 #98
20150267171
2015-09-24

ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE

 #99
20150259419
2015-09-17

Anti-MCAM Antibodies and Associated Methods of Use

 #100
20150246956
2015-09-03

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

 #101
20150191532
2015-07-09

Antibody for epitope tagging, hybridoma cell line and uses thereof

 #102
20150166678
2015-06-18

Compositions and methods comprising binding proteins for adalimumab

 #103
20150153356
2015-06-04

PEPTIDE AND ANTIBODY LIBRARIES AND USES THEREOF

 #104
20150140014
2015-05-21

Method of combination therapy using an anti-C-Met antibody

 #105
20150086564
2015-03-26

Anti-sPLA2-IIA antibodies and uses thereof

 #106
20140380515
2014-12-25

Transgenic transchromosomal rodents for making human antibodies

 #107
20140349393
2014-11-27

Fusion Partner for Production of Monoclonal Rabbit Antibodies

 #108
20140295455
2014-10-02

Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer

 #109
20140273031
2014-09-18

IN-VITRO METHOD FOR MONOCLONAL ANTIBODY PRODUCTION

 #110
20140248261
2014-09-04

Antibody against mutant α-actinin-4

 #111
20140235827
2014-08-21

Mouse anti-Aggrus monoclonal antibodies

 #112
20140234327
2014-08-21

Monoclonal antibody against human non-small cell lung carcinoma and use thereof

 #113
20140199319
2014-07-17

METHODS FOR INCREASING THE EFFICIENCY OF HYBRIDOMA GENERATION

 #114
20140170170
2014-06-19

Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof

 #115
20140148583
2014-05-29

Antibody that binds domain 2 of ICAM-1 and methods of treatment

 #116
20140099650
2014-04-10

Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme

 #117
20140004566
2014-01-02

Fusion partner for production of monoclonal rabbit antibodies

 #118
20130177987
2013-07-11

METHODS FOR DEVELOPING ANTIGEN-SPECIFIC ANTIBODY-PRODUCING CELL LINES AND MONOCLONAL ANTIBODIES

 #119
20130071325
2013-03-21

Monoclonal antibodies for treatment of cancer

 #120
20130022957
2013-01-24

Enhanced animal cell growth using ultrasound

 #121
20120238013
2012-09-20

Fusion partner for production of monoclonal rabbit antibodies

 #122
20120189540
2012-07-26

IL3Rα antibody conjugates and uses thereof

 #123
20120184719
2012-07-19

Hybridoma producing anti-methylated DNA antibody and utilization of same

 #124
20120141413
2012-06-07

Use of IL-15 preparations to treat lymphopenia

 #125
20120107848
2012-05-03

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

 #126
20120088272
2012-04-12

Methods of generating hybrid/chimeric cells, and uses thereof

 #127
20110311989
2011-12-22

Antibody to N-terminal region of hemoglobin β-chain

 #128
20110230649
2011-09-22

Compositions and methods for redox modulated proteins

 #129
20110111529
2011-05-12

Method for quantification of antigen-specific canine IgE

 #130
20110091483
2011-04-21

Canine anti-CD20 antibodies

 #131
20110065184
2011-03-17

Human host cell for producing recombinant proteins with high quality and quantity

 #132
20110020934
2011-01-27

Fusion partner for production of monoclonal rabbit antibodies

 #133
20110003319
2011-01-06

Transgenic trasnchromosomal rodents for making human antibodies

 #134
20110002937
2011-01-06

Method of making hybrid cells that express useful antibodies

 #135
20100297008
2010-11-25

Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors

 #136
20100287632
2010-11-11

Rapid production of monoclonal antibodies

 #137
20100107264
2010-04-29

Development of influenza A antivirals

 #138
20100047288
2010-02-25

Hybrid cells for treating cancer patients

 #139
20100029002
2010-02-04

Enhancement of hybridoma fusion efficiencies through cell synchronization

 #140
20100028946
2010-02-04

Fusion partner cells

 #141
20090325195
2009-12-31

POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP

 #142
20090252742
2009-10-08

IL3Rα antibody conjugates and uses thereof

 #143
20090142807
2009-06-04

Fusion partner for production of monoclonal rabbit antibodies

 #144
20090087450
2009-04-02

Combination therapy of hybrid cells with BCG injection for treating Cancer Patients

 #145
20090074728
2009-03-19

Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase

 #146
20090068679
2009-03-12

Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof

 #147
20090068172
2009-03-12

Compositions and methods comprising binding proteins for adalimumab

 #148
20080220431
2008-09-11

Cell fusion method

 #149
20080003679
2008-01-03

Cell culture medium

 #150
20070212338
2007-09-13

Hybrid cells

 #151
20070207539
2007-09-06

Genetically altered hybridomas, myelomas and B cells that facilitate the rapid production of monoclonal antibodies

 #152
20070160982
2007-07-12

Development of influenza A antivirals

 #153
20070154995
2007-07-05

Development of human monoclonal antibodies and uses thereof

 #154
20070141064
2007-06-21

Fully human hybridoma fusion partner cell lines

 #155
20070098711
2007-05-03

Methods of producing stable B-lymphocytes

 #156
20070082382
2007-04-12

Development of human monoclonal antibodies and uses thereof

 #157
20070065919
2007-03-22

Methods of producing stable B-lymphocytes

 #158
20070026455
2007-02-01

Method of producing hybridoma and utilization thereof

 #159
20070015259
2007-01-18

Fusion partner for production of monoclonal rabbit antibodies

 #160
20070010476
2007-01-11

Therapy and diagnosis of conditions related to telomere length and/or telomerase activity

 #161
20060292644
2006-12-28

Tumor-associated marker

 #162
20060172960
2006-08-03

Therapy and diagnosis of conditions related to telomere length and/or telomerase activity

 #163
20060154321
2006-07-13

Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP

 #164
20060078946
2006-04-13

Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody

 #165
20060037093
2006-02-16

Transgenic transchromosomal rodents for making human antibodies

 #166
20060026698
2006-02-02

Transgenic transchromosomal rodents for making human antibodies

 #167
20050221393
2005-10-06

Method of increasing product expression through solute stress

 #168
20050170454
2005-08-04

Cell culture medium

 #169
20050158244
2005-07-21

Hybrid cells

 #170
20050069535
2005-03-31

Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides

 #171
15254852
2019-06-25

Cell lines for high level production of protein-based pharmaceuticals